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Background: CTX is a rare congenital lipid-storage disorder, leading to a progressive multisystem disease. CTX 
with autosomal recessive inheritance is caused by a defect in the CYP27A1 gene. Chronic diarrhea, tendon 
xanthomas, neurologic impairment, and bilateral cataracts are common symptoms of the disease. Methods: 
Three affected siblings with an initial diagnosis of non-syndromic intellectual disability were recruited for further 
molecular investigations. To identify the possible genetic cause(s), WES was performed on the proband. Sanger 
sequencing was applied to confirm the final variant. The clinical and molecular genetic features of the three 
siblings from the new CTX family and other patients with the same mutations, as previously reported, were 
analyzed. The CYP27A1 gene was also studied for the number of pathogenic variants and their location. Results: 
We found a homozygous splicing mutation, NM_000784: exon6: c.1184+1G>A, in CYP27A1 gene, which was 
confirmed by Sanger sequencing. Among the detected pathogenic variants, the splice site mutation had the 
highest prevalence, and the mutations were mostly found in exon 4. Conclusion: This study is the first to report 
the c.1184+1G>A mutation in Iran. Our findings highlight the other feature of the disease, which is the lack of 
relationship between phenotype and genotype. Due to nonspecific symptoms and delay in diagnosis, 
CYP27A1 genetic analysis should be the definitive method for CTX diagnosis. DOI: 10.29252/ibj.25.2.132 
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erebrotendinous xanthomatosis is a rare 
autosomal recessive lipid storage disease 
caused by a defect in CYP27A1 gene, encoding 
the mitochondrial cytochrome P450 sterol 27-
hydroxylase enzyme
[1]
. As a result of this deficiency, 
certain metabolites, such as cholesterol and 
cholestanol, accumulate in various tissues, particularly 
eye lenses and muscle tendons, as well as in the central 
nervous system
[2,3]
. CTX has neurologic and systemic 
presentations
[4-6]
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